Ab&B Bio-Tech CO., LTD. JS

HK$29.32As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2627Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (27.25%)
Mkt cap HK$11.54B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$32
9.60%
(86.89%)
Hold 4|10|9|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.28
0.31
0.33
0.35
1.81%
13.71%
21.63%
18.48%
Revenue¥B
1.114
1.155
1.129
1.104
4.20%
10.75%
9.66%
4.25%
Peers (US$1.471B)
Cap (US$)
PE
1.515B
13.84x
1.503B
343.0x
1.450B
253.8x
Capital
TTM
5Y
10Y
Leveragex
1.230
(0.037)
(0.034)
EBIT/Intx
0.287
0.062
0.061
Own earn%
(14.70)
492.66
404.83
Sh yield%
31.58
27.66
25.74
Owners
Insiders/Inst%
13.20
32.13
Short interest%
5.79
SBC / revenue%
0.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
9